ImmuCell Corporation (ICCC) Operating Margin
- Operating margin · 12 months: Value 12.60%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 12.60% | Operating income / revenue. Period ending 2026-06-30. $3.87M ÷ $30.68M × 100 ≈ 12.60% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 3.87M USD | Operating Income (Loss) |
| Revenue | 30.68M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 1.89M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.87M | $30.68M | (m) | $1.89M | (m) | 12.60% |
| 2026-03-31 | $2.50M | $29.93M | (m) | $2.60M | (m) | 8.35% |
| 2025-12-31 | $1.65M | $27.64M | (m) | $3.04M | (m) | 5.97% |
| 2025-09-30 | $2.33M | $27.77M | (m) | $3.10M | (m) | 8.39% |
| 2025-06-30 | $1.73M | $28.27M | $17.69M | $3.19M | (m) | 6.13% |
| 2025-03-31 | $-222.48K | $27.30M | $18.30M | $3.39M | (m) | -0.81% |
| 2024-12-31 | $-1.64M | $26.49M | $18.55M | $3.90M | (m) | -6.19% |
| 2024-09-30 | $-3.27M | $23.84M | $17.47M | $4.15M | (m) | -13.70% |
| 2024-06-30 | $-3.87M | (m) | $17.17M | $4.48M | (m) | (m) |
| 2024-03-31 | $-3.79M | (m) | $15.42M | $4.55M | (m) | (m) |
| 2023-12-31 | $-5.75M | $17.47M | $13.60M | $4.39M | (m) | -32.90% |
| 2023-09-30 | $-6.38M | $16.29M | $12.68M | $4.38M | (m) | -39.16% |
| 2023-06-30 | $-5.81M | (m) | $11.50M | $4.53M | (m) | (m) |
| 2023-03-31 | $-5.13M | (m) | $11.17M | $4.57M | (m) | (m) |
| 2022-12-31 | $-2.30M | (m) | $10.92M | $4.49M | (m) | (m) |
| 2022-09-30 | $-519.78K | $20.10M | $10.88M | $4.53M | (m) | -2.59% |
| 2022-06-30 | $590.48K | (m) | $10.67M | $4.31M | (m) | (m) |
| 2022-03-31 | $1.42M | (m) | $10.98M | $4.17M | (m) | (m) |
| 2021-12-31 | $257.38K | (m) | $10.59M | $4.17M | (m) | (m) |
| 2021-09-30 | $-522.39K | (m) | $9.83M | $4.25M | (m) | (m) |
| 2021-06-30 | $-1.05M | (m) | $9.09M | $4.32M | (m) | (m) |
| 2021-03-31 | $-1.95M | (m) | $8.31M | $4.41M | (m) | (m) |
| 2020-12-31 | $-1.38M | (m) | $8.48M | $4.35M | (m) | (m) |
| 2020-09-30 | $-988.45K | (m) | $8.15M | $4.16M | (m) | (m) |
| 2020-06-30 | $-1.17M | (m) | $7.67M | $4.02M | (m) | (m) |
| 2020-03-31 | $-1.02M | (m) | $7.45M | $3.75M | (m) | (m) |
| 2019-12-31 | $-953.91K | (m) | $6.98M | $3.69M | (m) | (m) |
| 2019-09-30 | $-1.64M | (m) | $6.73M | $3.98M | (m) | (m) |
| 2019-06-30 | $-1.36M | (m) | $6.41M | $3.90M | (m) | (m) |
| 2019-03-31 | $-1.00M | (m) | $6.48M | $3.84M | (m) | (m) |
| 2018-12-31 | $-1.45M | (m) | $5.79M | $3.52M | (m) | (m) |
| 2018-09-30 | $-934.04K | (m) | (m) | $2.99M | (m) | (m) |
| 2018-06-30 | $-1.27M | (m) | (m) | $2.66M | (m) | (m) |
| 2018-03-31 | $-1.34M | (m) | (m) | $2.29M | (m) | (m) |
| 2017-12-31 | $-242.84K | (m) | (m) | $2.05M | (m) | (m) |
| 2017-09-30 | $289.80K | (m) | (m) | $1.57M | (m) | (m) |
| 2017-06-30 | $822.68K | (m) | (m) | $1.29M | (m) | (m) |
| 2017-03-31 | $1.11M | (m) | (m) | $1.28M | (m) | (m) |
| 2016-12-31 | $890.20K | (m) | (m) | $1.24M | (m) | (m) |
| 2016-09-30 | $1.23M | (m) | (m) | $1.32M | (m) | (m) |
| 2016-06-30 | $1.81M | (m) | (m) | $1.32M | (m) | (m) |
| 2016-03-31 | $2.00M | (m) | (m) | $1.21M | (m) | (m) |
| 2015-12-31 | $2.12M | (m) | (m) | $1.24M | (m) | (m) |
| 2015-09-30 | $1.86M | (m) | (m) | $1.37M | (m) | (m) |
| 2015-06-30 | $1.27M | (m) | (m) | $1.43M | (m) | (m) |
| 2015-03-31 | $601.09K | (m) | (m) | $1.92M | (m) | (m) |
| 2014-12-31 | $-206.40K | (m) | (m) | $2.18M | (m) | (m) |
| 2014-09-30 | $-615.23K | (m) | (m) | $2.04M | (m) | (m) |
| 2014-06-30 | $-816.05K | (m) | (m) | $1.97M | (m) | (m) |
| 2014-03-31 | $-333.66K | (m) | (m) | $1.48M | (m) | (m) |
| 2013-12-31 | $-19.55K | (m) | (m) | $1.15M | (m) | (m) |
| 2013-09-30 | $202.92K | (m) | (m) | $1.06M | (m) | (m) |
| 2013-06-30 | $276.76K | (m) | (m) | $996.42K | (m) | (m) |
| 2013-03-31 | $290.43K | (m) | (m) | $936.27K | (m) | (m) |
| 2012-12-31 | $245.00K | (m) | (m) | $917.60K | (m) | (m) |
| 2012-09-30 | $241.88K | (m) | (m) | $954.36K | (m) | (m) |
| 2012-06-30 | $135.62K | (m) | (m) | $1.03M | (m) | (m) |
| 2012-03-31 | $-334.63K | (m) | (m) | $1.50M | (m) | (m) |
| 2011-12-31 | $-632.73K | (m) | (m) | $1.72M | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-690.28K | (m) | (m) | $1.49M | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-529.91K | (m) | (m) | $1.64M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |